Article info
Oral Presentations
Abstract session: Novel treatment in SLE and Sjögren’s syndrome
OP0118 Epratuzumab Mediates BCR-Antigen Trogocytosis as Potential Mechanism of Action in Systemic Lupus Erythematosus (SLE)
Citation
OP0118 Epratuzumab Mediates BCR-Antigen Trogocytosis as Potential Mechanism of Action in Systemic Lupus Erythematosus (SLE)
Publication history
- First published January 23, 2014.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions